A detailed history of Frank, Rimerman Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 16,457 shares of DHR stock, worth $4.44 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
16,457
Previous 2,229 638.31%
Holding current value
$4.44 Million
Previous $556,000 639.39%
% of portfolio
0.29%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$235.51 - $267.98 $3.35 Million - $3.81 Million
14,228 Added 638.31%
16,457 $4.11 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $534,402 - $617,433
2,229 New
2,229 $562 Million
Q2 2022

Sep 07, 2023

SELL
$237.11 - $299.66 $71,133 - $89,898
-300 Reduced 11.86%
2,229 $565 Million
Q3 2021

Sep 07, 2023

BUY
$272.21 - $332.43 $81,663 - $99,729
300 Added 13.46%
2,529 $770 Million
Q4 2020

Sep 13, 2023

BUY
$212.5 - $245.46 $78,625 - $90,820
370 Added 16.6%
2,599 $577 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.